Search Results - "receptor tyrosine kinase"

A systematic review of epidermal growth factor receptor tyrosine kinase inhibitor-induced heart failure and its management by Mohammad Nawaf AlShatnawi, Rzan Atef Shawashreh, Mohammed Ashraf Sunoqrot, Ali Rezeq Yaghi

Connect to this object online.

Inhibition of cotranslational translocation by apratoxin S4: Effects on oncogenic receptor tyrosine kinases and the fate of transmembrane proteins produced in the cytoplasm by Weijing Cai, Ranjala Ratnayake, Mengxiong Wang, Qi-Yin Chen, Kevin P. Raisch, Long H. Dang, Brian K. Law, Hendrik Luesch

Connect to this object online.

Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro by Johanna Weiss, Dirk Theile, Zdenek Dvorak, Walter Emil Haefeli

Connect to this object online.

Soluble TAM Receptor Tyrosine Kinases Correlate with Disease Severity and Predict the Early Responsiveness of Sublingual Immunotherapy in Allergic Rhinitis by Zhou Y, Feng Z, Wen J, Yang C, Jing Q

Connect to this object online.

Receptor tyrosine kinase C-kit promotes a destructive phenotype of FLS in osteoarthritis via intracellular EMT signaling by Xu Cao, Song Wu, Xinxing Wang, Junjie Huang, Wenxiu Zhang, Chi Liang

Connect to this object online.

In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation by Elshaymaa I. Elmongy, Najla Altwaijry, Nashwah G. M. Attallah, Manal Mubarak AlKahtani, Hanan Ali Henidi

Connect to this object online.

Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases by Ruixin Gu, Wei Zhang, Dandan Xu

Connect to this object online.

Safety profile of vascular endothelial growth factor receptor tyrosine-kinase inhibitors in pediatrics: a pharmacovigilance disproportionality analysis by Yifei Xue, Shuo Feng, Guangyao Li, Chao Zhang

Connect to this object online.

Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients by Ji Su Lee, Jimin Woo, Tae Min Kim, Namkyu Kim, Bhumsuk Keam, Seong Jin Jo

Connect to this object online.

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy by Hyung Kyu Park, Youjeong Seo, Yoon-La Choi, Myung-Ju Ahn, Joungho Han

Connect to this object online.

Computer-aided scoring of erb-b2 receptor tyrosine kinase 2 (HER2) gene amplification status in breast cancer by Alyson Yoder, Landon J. Inge, Chen-Chun Chen, Vijay R. Marati, Trung Kien Nguyen, Karel Zuiderveld, Jim Martin, Sarah Gladden, Mohammad Saleh Miri, Raghavan Venugopal, Bryan Lopez, Jim Ranger-Moore, Christoph Guetter

Connect to this object online.

Adverse event profiles of epidermal growth factor receptor‐tyrosine kinase inhibitors in cancer patients: A systematic review and meta‐analysis by Xiaonan Yin, Zhou Zhao, Yuan Yin, Chaoyong Shen, Xin Chen, Zhaolun Cai, Jian Wang, Zhixin Chen, Yiqiong Yin, Bo Zhang

Connect to this object online.

Correction to: Fischer et al., Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance

Connect to this object online.

Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies by Adel S. El-Azab, Abdullah Al-Dhfyan, Alaa A.-M, Laila A. Abou-Zeid, Hamad M. Alkahtani, Abdulrahman M. Al-Obaid, Manal A. Al-Gendy

Connect to this object online.

An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma by Sorah Yoon, Xiwei Wu, Brian Armstrong, Nagy Habib, John J. Rossi

Connect to this object online.

Benzofuran-appended 4-aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies by Malose J. Mphahlele, Marole M. Maluleka, Abimbola Aro, Lyndy J. McGaw, Yee Siew Choong

Connect to this object online.

Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods by Rezvan Rezaee Nasab, Mahboubeh Mansourian, Farshid Hassanzadeh, Mohsen Shahlaei

Connect to this object online.

G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models by Hae Dong Kim, Hae Dong Kim, Eun Jung Park, Eun Jung Park, Eun Kyoung Choi, Seuk Young Song, Kwang-Lae Hoe, Dong-Uk Kim

Connect to this object online.

MicroRNA-27b-3p regulates function and metabolism in insulin resistance cells by inhibiting receptor tyrosine kinase-like orphan receptor 1 by Yong Liu, Guohui Wang, Xiangwu Yang, Pengzhou Li, Hao Ling, Shaihong Zhu

Connect to this object online.

Synthesis and In Vitro Cytotoxicity of the 4-(Halogenoanilino)-6-bromoquinazolines and Their 6-(4-Fluorophenyl) Substituted Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase by Malose Jack Mphahlele, Hugues K. Paumo, Yee Siew Choong

Connect to this object online.